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ABSTRACT 
The purpose of this project was to improve the monitoring of chronic pain patients at a 
rural primary care clinic by creating and implementing a chronic pain flow sheet and pain visit 
template within the electronic health record. These evidence-based tools were developed using 
published guidelines regarding the monitoring of chronic pain patients. The clinic has three 
providers, one physician and two advanced practice providers, and provides primary care along 
with an extensive amount of chronic pain management.  
An initial survey was performed on the three providers via a questionnaire along with 
open discussion regarding their current chronic pain management practice. All providers reported 
treating chronic pain patients was difficult and the electronic health record was currently not 
user-friendly when monitoring chronic pain patients. The flow sheet and pain visit template was 
designed by the project leader (writer) and created by the Computer Information Systems (CIS) 
department. Once it was created, an initial chart review and flow sheet implementation was 
performed on a sample population of adult chronic pain patients at the clinic. Providers were 
educated on the available flow sheet along with the pain visit template available for use.  
A six-month chart review was conducted to evaluate the project and determined how the 
flow sheet and template were utilized. A post-implementation survey, similar to the initial 
questionnaire, was also dispensed and analyzed. Results indicate providers do plan to use the 
designed monitoring tools but there were some barriers standing in the way of consistent use. 
The chart review found an increase in presence of pain contracts signed and filed within the last 
year, but a decrease in the presence of a pain visit within the last four months, urine drug screen 
within the last six months, and the prescription drug monitoring program checked within the last 
six months. 
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CHAPTER ONE. INTRODUCTION 
Opioid abuse is a prevalent problem in the United States with potentially lethal 
complications. Because of the medical and ethical implications of opioid therapy providers are 
hesitant to prescribe opioids, despite their evidence-based effectiveness in caring for chronic 
pain. In order to understand opioid abuse, one must define what opioid abuse is and the 
associated behaviors.  
Definitions 
Substance misuse is defined as “the use of any drug in a manner other than how it is 
indicated or prescribed”. Substance abuse is defined as “the use of any substance when such use 
is unlawful, or when such is detrimental to the user or others”. Addiction occurs when the abused 
substance is used out of control, compulsively, or its use continues despite potential harm 
(Butler, Fernandez, Benoit, Budman, & Jamison, 2008, p. 361). 
 Unfortunately, prescription opioids are substances that are commonly abused. Opioids act 
on the central nervous system as a depressant and in return, deliver an analgesic effect and a state 
of euphoria. Several examples of opioids exist, including heroin, morphine, codeine, fentanyl, 
and oxycodone. Because of their euphoric and addictive properties, a craving or desire for 
opioids cause aberrant drug-related behaviors. These behaviors are “any behaviors that imply 
misuse of prescription medications” (Butler et al., 2008, p.361). Aberrant behaviors include any 
behavior consistent with abuse, addiction, or diversion. Examples include stealing medications, 
using medications for non-prescribed reasons, or abusing opioids in conjunction with illicit 
substances.  
 
 
 
 
2
Prevalence  
 Despite the increase in misuse behaviors, the use of therapeutic opioids continues on the 
rise. In fact, the supply of opioids drastically increased over the past 13 years, increasing from 
96mg of morphine equivalence per person in 1997 to 710mg per person in 2010. This is enough 
opioid to supply every American adult with 5mg hydrocodone every 6 hours for 45 days. 
Although opioids are available worldwide, America consumes 99% of the global consumption of 
hydrocodone and 83% of oxycodone (Manchikanti et al., 2012).  
The Impact of Opioid Abuse 
 Substance use disorders are one of the most common psychiatric disorders in the United 
States, affecting 20% of the population (Moore, Jones, Browder, Daffron, & Passik, 2009). 
Opioid abuse causes health hazards and has a negative economic impact on the country.  
Adverse Effects of Opioids  
 Substance abuse leads to dependence, decreased sexual functioning, interpersonal 
violence, risky sexual behavior, and neurological and cognitive impairments (Moore et al., 
2009). Health side effects from opioids can affect nearly every body system. Neurological side 
effects include hyperalgesia, sedation, and muscle rigidity. Nausea, vomiting, and constipation 
are common gastrointestinal side effects. Although not common or well known, cardiac 
dysrhythmias and sleep apnea can occur secondary to opioid use. The kidneys may be affected 
with the use of opioids causing decreased renal function and peripheral edema. Hypogonadism, 
sexual dysfunction, and immune suppression are also side effects of opioid use (Harris, 2008).   
 Drug overdoses are now the leading cause of injury-related deaths in the United States. 
Forty-four thousand people die annually from drug overdose, which has more than doubled in 
the past 14 years (Brooks, 2015). In 2008, deaths related to overdose exceeded deaths related to 
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motor vehicle accidents for the first time since 1980. Of the 36,500 drug poisoning deaths in 
2008, 40% involved opioid analgesics (Warner, Chen, Makuc, Anderson, & Minino, 2011).  
Economic Impact 
 The continued epidemic of prescription opioid abuse not only causes adverse health 
effects; it negatively impacts the country’s economy. In 2001, the cost of opioid abuse was $11.8 
billion and 53% was attributed to lost workplace productivity, 30% to healthcare, and 17% to 
criminal justice. Excess costs per privately insured patient due to opioid abuse was estimated to 
be at $17,768 per patient (Birnbaum et al., 2011, 657).  
 A research article published in 2011 in Pain Medicine examined the societal costs of 
opioid abuse in 2007 and compared the 2001 numbers. The study showed that opioid abuse has 
grown in the past six years and caused a worsening economic impact. Results showed the 2007 
cost of opioid abuse is $55.7 billion, $25.6 billion spent on lost workplace productivity, $25 
billion on healthcare costs, and $5.1 billion on criminal justice. Opioid abuse not only affects the 
individual with opioid related aberrant behaviors, but affects the entire economy, from taxpayers 
to employers (Birnbaum et al, 2011, 661-662). The Center for Disease Control and Prevention 
performed a more recent analysis showing the total economic burden of opioid abuse totals $78.5 
billion a year (Anson, 2016).  
The Face of Opioid Abuse 
 Ingesting opioids in excess amounts, or for reasons besides therapeutic indication, is done 
for various reasons or motives. Personal history, life stressors, and characteristics can lead 
someone to be more apt to abuse opioids. In order to detect opioid abuse in patients, readers 
should understand the motivation and characteristics behind opioid abuse.  
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Motivation for Abuse 
 Research has shown substance abuse occurs for a variety of motives. A study performed 
on undergraduate psychology students involved a questionnaire regarding their use of 
prescription opioids and choosing the motives behind the use. Reasons for use were divided into 
four categories: enhancement, coping, social, and pain. Examples of specific reasons for use 
besides their indicated use for pain include “because it’s fun”, “because it gives you a pleasant 
feeling”, “because you feel more self-confident or sure of yourself”, and “because it improves 
parties and celebrations” (Jones, Spradlin, Robinson, & Tragesser, 2014). 
Patient Characteristics of Opioid Abuse 
 A study was conducted in a Boston, MA hospital on medical inpatients with acute pain 
suspected of non-medical opioid abuse (Jamison, Butler, Edwards, & Wasan, 2010). Of the 
population evaluated for possible non-medical use of opioids, 77.8% had a psychiatric disorder, 
such as major depression or bipolar depression and 88.9% had a diagnosis of substance use 
disorder, such as opioids, alcohol, cocaine, or cannabis. Over sixty-six percent of the patients 
selected for evaluation were also prescribed a psychiatric medication, such as antidepressants, 
mood stabilizer, antipsychotic, benzodiazepine, and stimulants (Jamison, Butler, Edwards, & 
Wasan, 2010). 
 Gender differences also exist between male and female patients abusing opioids. Women 
are shown to have a higher incidence of pain and are prescribed opioids more often than men. 
Substance abuse behavior is more prevalent in men. A history of depression and sexual abuse are 
more frequent in substance misuse and are more common in women. “Gender Differences in 
Risk Factors for Aberrant Prescription Opioid Use” was a research study published in 2010 that 
interviewed chronic non-cancer pain patients from pain management centers in five different 
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states in the United States (Jamison, Butler, Edwards, & Wasan, 2010). Results showed “women 
tended to endorse items that are based more on emotional issues and affective distress compared 
with men. Conversely, men scored higher on opioid misuse behaviors such as associating with 
others who abuse drugs and alcohol and engaging in criminal behavior. Men reported less mood 
problems than women but were more likely to admit behavioral problems leading to abuse” 
(Jamison, Butler, Edwards, & Wasan, 2010, p. 316).  
Opioid Craving 
 Craving related to substance abuse is defined as “a strong desire for or urge to imbibe 
psychoactive substances, such as drugs, alcohol, and tobacco” (Wasan et al., 2012, p. 146). 
Prescription opioid cravings are associated with an elevated rate of opioid misuse. A research 
article titled “Craving of Prescription Opioids in Patients with Chronic Pain: A Longitudinal 
Outcomes Trial” looked at 62 patients with low to high risk of opioid misuse while they were 
enrolled in a randomized control trial to improve prescription opioid medication adherence. 
Participants showed intense opioid craving correlated with urge, preoccupation, and mood. The 
study argued that intervening to decrease patients’ cravings will potentially reduce opioid misuse 
and improve adherence (Wasan et al., 2012).  
Problem Statement 
Opioid abuse is a growing epidemic. Deaths from overdoses are increasing in number. 
Healthcare costs continue to rise due to opioid abuse and inadequate chronic pain management. 
Primary care providers feel inexperienced and uncomfortable with managing opioid therapy 
safely and effectively. To address this problem, a monitoring and documentation tool was 
developed within the electronic health record to assist primary care providers serving chronic 
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pain patients in a rural primary care clinic. The purpose of this project was to implement 
evidence-based practices for prescribing opioids for chronic pain management and monitoring. 
Project Objectives 
Objective One 
  The first objective was to assess the providers’ perception of their current chronic pain 
management process in regards to usability, efficiency, and overall comfort level in caring for 
the chronic pain patient population. This information was obtained through a developed survey 
(Appendix B) delivered to the clinic providers. The goal was to find a level of improvement in 
providers’ perception of their practice of caring for chronic pain patients after the 
implementation of the tools mentioned below.  
Objective Two  
 The second objective was to create and implement evidence-based chronic pain 
documentation and monitoring tools to be used within the electronic health record. Tools 
included a template to be used when documenting a pain visit along with a flow sheet to easily 
monitor important parameters of chronic pain patients. The goal of this objective was for 
providers to find the tools to be useful in practice and for the comparative data from the chronic 
pain patients’ chart review to show improvement in chronic pain monitoring parameters. The 
monitoring parameters within the chronic pain flow sheet included:  
• Urine drug screen performed within the past six months 
• Pain visit within the last 3-4 months 
• Pain agreement signed and filed within the last one year 
• If a query was done on prescription drug monitoring program with the last new or refilled 
opioid prescription  
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CHAPTER TWO. LITERATURE REVIEW OF EVIDENCE-BASED PRACTICE 
 A literature review was performed using databases containing evidence-based articles to 
contribute and support the objectives of this practice improvement project. Databases that were 
used included EBSCO, Cinahl, and PubMed. Topics searched focused on chronic pain, safe 
opioid prescribing, documentation of pain visits, and monitoring chronic pain patients. 
Essential Monitoring Elements in Chronic Pain Patients 
 Many clinicians feel a structured approach that is applied uniformly across patient groups 
helps meet the challenges of monitoring each patient on long-term opioid therapy. Several 
computerized systems are in existence but patient care can be greatly improved with systems that 
contain tools for collecting, analyzing, and utilizing outcomes. Tips for effective monitoring 
include: listening carefully and compassionately, attending to entire patient (not just the pain), 
referring to relevant health professionals as needed (such as pain centers or mental health 
professionals), adjusting pain medications, modifying functional goals, and collaborating with 
the patient on their treatment plan (Fisherman, 2012).  
An opioids special issue was published in 2008 in the Pain Physician journal titled, 
“Monitoring Opioid Adherence in Chronic Pain Patients: Tools, Techniques and Utility”. The 
aim of the review was to address the issues of hesitancy in prescribing opioid medications due to 
risk of patient misuse and/or potential for professional prosecution. The authors emphasized the 
importance of adherence monitoring in order to avoid misuse and abuse, but also ensuring proper 
pain management (Manchikanti, Atluri, Trescot, & Girodano, 2008). Tools and monitoring 
measures include urine drug testing, prescription drug monitoring programs, and controlled 
substance agreements. 
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Urine Drug Screens 
 Urine drug testing in chronic pain patients is becoming more prevalent in practice and 
serves to test for adherence and identify presence of illicit drugs or other medications that are not 
prescribed to the patient. The test has relatively good specificity, sensitivity, ease of 
administration, and low cost. However, no urine test can test for the presence or absence of all 
drugs; but urine drug screens can provide useful information to the prescriber if considering 
whether or not to continue prescribing opioid medication (Manchikanti et al, 2008). 
Interpretation of the urine drug screening needs to be done in conjunction with patient’s 
history as each substance metabolizes differently (Manchikanti et al, 2008). For example, 
cocaine, codeine, and heroin are detected in the urine for 1-3 days after use but benzodiazepines 
can stay in the urine for up to 30 days, which is the same for chronic marijuana use. Another 
caveat of interpreting urine drug screens (UDS) is knowing the end product metabolite of opioid 
medication. An example of this is codeine, a UDS showing positive for morphine is appropriate 
as codeine is metabolized into morphine (Manchikanti et al, 2008). 
Despite the potential limitations of urine drug screening, evidence shows that urine drug 
screens are beneficial in providing prescribers objective data. Also, “studies suggest that 
behavior monitoring alone in patients on chronic opioid treatment will fail to detect potential 
problems revealed by urine toxicology testing”. In fact, that study showed that “one in five 
patients who appeared to be taking opioids as prescribed by an expert clinician had a positive 
urine screen for an illicit drug” (Sehgal, Manchikanti, & Smith, 2012, p. ES78). Because of the 
urine drug testing performed in this study’s sample, 40% were referred to behavioral health and 
addiction specialists and 19.6% of patients were diagnosed with drug abuse and addiction. Data 
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from this study supports the practice of collecting urine drug screens on patients receiving 
opioids, regardless of signs or symptoms of drug misuse (Sehgal et al., 2012).  
Schneider, a board certified physician in internal medicine, addiction medicine, and pain 
management, makes suggestions regarding the frequency of UDS. She points out that published 
guidelines do not specify a frequency but she recommends only doing random UDS since 
patients can plan and prepare if they know the schedule of UDS collection. In her practice, 
samples are obtained at random, 2-3 times a year, and additionally if there are concerns about 
adherence (Schneider, 2014). Fisherman, a physician who specializes in pain management, 
warns of “white coat compliance”. An example of white coat compliance is when an abuser 
diverting opioids attempts to appear compliant by taking the medication only prior to a scheduled 
or anticipated urine drug screen (Fisherman, 2012).  
Prescription Drug Monitoring Program (PDMP) 
 The PDMP is a statewide electronic database that collects data on controlled substances 
dispensed in the state. The PDMP is housed by a specified statewide regulatory, administrative 
or law enforcement agency (U.S. Department of Justice, 2011). The housing agency distributes 
data from the database to individuals who are authorized under state law to receive the 
information for purposes of their profession. Data collected as of October 2011 shows 37 states 
with operational PDMPs and 11 states with the legislation to establish a PDMP (U.S. Department 
of Justice, 2011).  
 According to “Monitoring Opioid Adherence in Chronic Pain Patients: Tools, Techniques 
and Utility” (2008, p. 18-19), the majority of state PDMPs have the following goals: 
• To educate and inform practitioners and the public 
• To develop and advance public health initiatives  
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• To facilitate early identification and intervention in cases of drug misuse or abuse 
• To aid in investigation and law enforcement 
• To safeguard the integrity, and access to the programs’ database  
A report by the Office of Justice Programs found that the presence of the PDMP may reduce per 
capita supply of prescription pain medications (Manchikanti et al., 2008). 
 A research study performed using the prescription records from a Massachusetts 
prescription monitoring program (PMP) for Schedule II opioids over a ten-year timeframe found 
the number of prescriptions, doses prescribed, and individuals receiving Schedule II 
prescriptions steadily increased during that timeframe. They found the use of the prescription 
monitoring program has the ability to capture relevant data regarding opioid dispensing, 
including activity that may be indicative of misuse. Several variables of the PMP were found to 
be suggested indicators of inappropriate use, such as number of dosage units dispensed, number 
of prescribers, and number of pharmacies used. Researchers in this study felt that the use of the 
state PMP can be beneficial on many levels. The program provides individual patient data to 
providers regarding level of pain management, administrative problems, abuse, addiction, and 
diversion. Community risk data can also be obtained by looking at questionable activity and 
negative health outcomes and help initiate appropriate interventions. Lastly, it has the potential 
to help identify questionable activity at both the patient and prescriber level that may warrant 
further investigation (Katz et al., 2010).  
 In 2012, New York required prescribers to check the PDMP before prescribing 
painkillers, resulting in a 75 percent drop in patients seeing multiple prescribers for the same 
drugs. That same year in Tennessee, the same rule was introduced and the state saw a 36% 
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decline in patients seeing multiple prescribers for the same drugs (PDMP Center for Excellence, 
2014).  
 The Minnesota Prescription Monitoring Program is administered by the MN Board of 
Pharmacy and collects prescription data on all schedule II-IV controlled substances (MN 
Prescription Monitoring Program, 2015).  The database contains information about controlled 
substance prescriptions that were dispensed in or into the state of MN. A check of the PDMP 
reveals the recipient, name of prescription medication, quantity of prescription medication, name 
of prescriber, and date and location of where prescription was dispensed. Prescribers and 
dispensers are not required to use the database and the program is not intended to prevent 
patients from receiving necessary medications (MN Prescription Monitoring Program, 2015).  
Controlled Substance Agreements 
 Controlled substance agreements are considered invaluable tools in pain management and 
serve to clarify parameters of treatment, explain patient and provider responsibility, inform 
patients of expectations, and address potential consequences if obligations and responsibilities 
are not upheld (Manchikanti et al., 2008). Rhode Island internal medicine residents were 
surveyed on their opinion of the usefulness of pain medication agreements (PMA) and 90% 
stated they were broadly useful and helpful in reducing multiple prescribers, reducing requests 
for early refills, decreasing calls and pages from patients requesting additional drugs, discussing 
potential problems associated with chronic opioid use, and identifying patients who are abusing 
pain medications. Ideally, the agreement should contain information about the risks, benefits, and 
possible complications of long-term opioid therapy and outline what a violation would entail and 
the consequence that would ensue (Manchikanti et al., 2008).  
 
 
12 
 A narrative review by Sehgal, Manchikanti, and Smith (2012) discusses opioid treatment 
agreements and reports similar benefits as the sources mentioned above. The authors mention 
that the agreements may be perceived as controversial because of their intent, elements, language 
and tone, readability, physician responsibility, and legal risk. There is a lack of evidence showing 
that these agreements are effective in decreasing opioid abuse but are still widely supported and 
in some states, mandated (Sehgal, Manchikanti, & Smith, 2012).  
 As stated above, formalized agreements have not been validated to improve efficacy. 
They are, however, recommended by regulators and experts on treatment guidelines for long-
term opioid therapy. The Veteran’s Administration (VA) and the Department of Defense (DoD), 
which manage America’s largest health systems, performed a 2-year systematic review of 
medical literature on the use of the opioid treatment agreements. The VA and DoD released in 
their evidence-based guidelines that the use of opioid treatment agreements are a standard of care 
when prescribing long-term opioid therapy (Fisherman, 2012).  
Chronic Pain Visits and Documentation 
 In performing a literature review for the evidence-based recommendations on chronic 
pain visits and the essential documentation elements to include in those visit notes, there is a lack 
of standardized and detailed recommendations. This may be due to the highly individualized 
aspect of chronic pain management and how every patient and his/her circumstance is unique. 
Clinicians need to use their clinical expertise to help determine their follow-up plan for each 
patient and consider the patient’s risk of opioid abuse, co-morbidities, and the level of 
effectiveness of their current treatment plan.  
 Schneider provides her recommendations on assessment, documentation, and follow-up 
visits for chronic pain patients (Schneider, 2014). Assessment of chronic pain is commonly 
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based on the 4 A’s: analgesia (the level of pain or the level of pain relief), activities of daily 
living (what does the patient do on a daily basis and how does the pain interfere with those 
activities), adverse effects, and aberrant behaviors (requesting early refills or having a positive 
UDS for illicit drugs). Schneider (2014) also recommends a 5th A, affect. Depression and anxiety 
often exacerbate pain and many chronic pain patients are clinically depressed (Schneider, 2014). 
 Frequency of visits is very dependent on the rapport between the provider and the patient. 
A visit every 1-2 months for stable patients is recommended, and if the patient is considered to 
be on a relatively low dose of opioids, every 3 months is appropriate. In patients with adherence 
or abuse issues, these patients should be seen every 1-2 weeks and may also need additional 
contact via phone or electronic messaging between visits. The frequency of visits should also be 
considered in conjunction with whether or not a provider should prescribe without an office visit. 
Published guidelines do not require an office visit for every controlled substance prescription and 
the DEA permits writing multiple prescriptions for Schedule II drugs for up to 90 days as long as 
they are dated appropriately and have do not fill until x date included (Schneider, 2014). 
 Fisherman (2012) recommends the intensity and frequency of monitoring chronic pain 
patients depend on the patient’s risk for abuse, diversion, or addiction. States vary on their 
requirements for intervals at which follow-up visits are required when controlled substances are 
prescribed. Patients requiring more intense monitoring include history of prior addiction, abuse, 
or aberrant use, occupations demanding more mental acuity, older adults, unstable or 
dysfunctional social environment, and comorbid psychiatric or medical conditions (Fisherman, 
2012).  
Prescribers should be motivated to diligently chart pain visits. Schneider (2014) points 
out that documentation is rarely a reason for scrutiny or prosecution in hypertension or diabetes, 
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but is very common with the treatment of chronic pain patients with opioids (Schneider, 2014). 
“A Review of Forensic Implications of Opioid Prescribing with Examples from Malpractice 
Cases Involving Opioid-Related Overdose” discussed malpractice lawsuits involving patients 
who overdosed while consuming therapeutic opioids (Rich & Webster, 2011). Physician error 
and non-adherence by patients were common contributory factors in prescription drug deaths. 
Prescriber errors included initiating doses too high for opioid-naïve patients, incorrect titration or 
dose conversion, and concurrent use of benzodiazepines. Physicians encountered legal problems 
on both ends of the pain management spectrum in prescribing opioids in patients with a clear risk 
of abuse and on the other hand, strictly withholding necessary pain medication for patients in 
need out of fear of being prosecuted. The study pointed out the obvious clinical challenge these 
patients create and recommend seeking education on providing competent care to pain patients 
and also being knowledgeable of regulatory policies and laws (Rich & Webster, 2011). 
Prescribing practices that can warrant scrutiny include issuing prescriptions for large 
amounts of controlled substances without medical justification, failing to keep accurate records, 
and failing to evaluate and/or monitor patients. Another practice that may raise suspicion 
includes prescribing drug-dependent persons without adequate consultation, evaluation, and 
monitoring (Unite States Department of Justice, Drug Enforcement Administration, 2010).  
Fisherman (2012), a leading pain medicine clinician, explains how documentation that is 
clear, consistent, and detailed is part of “best practice”. Proper documentation includes essential 
information including effectiveness of treatment regimen and the clinician’s rationale for 
treatment. Key elements of effective documentation include: assessment, education, treatment 
agreement and informed consent, action plans, outcomes, and monitoring (Fisherman, 2012).  
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Recommendations for Providers 
Clinical guidelines in regards to the safe prescribing practices of opioid therapy are 
available and have similar recommendations for practice. American Society of Interventional 
Pain Physicians and the Center for Disease Control and Prevention have both written guidelines 
in regards to chronic pain management and monitoring.  
American Society of Interventional Pain Physicians 
The “American Society of Interventional Pain Physicians (ASIPP) guidelines for 
responsible opioid prescribing in chronic non-cancer pain: Part 2- guidance” (2012) provides a 
thorough background of opioid abuse, recommendations for practice, and user-friendly materials 
to utilize in the clinic setting. The recommendations are organized chronologically and outline 
directions for use with each category. Opioid therapy begins with a comprehensive assessment 
that further details the chronic pain but also looks at the psychological aspect of pain, along with 
the medical and surgical history. This section also includes performing an addiction risk-
screening tool and if necessary, checking a urine drug screen and prescription monitoring 
program (Manchikanti, 2012). 
 Establishing a diagnosis is the next step and may include a consult or diagnostic imaging. 
Important steps in determining if opioids are appropriate include establishing medical necessity 
and establishing treatment goals. Criteria for meeting medical necessity for opioid therapy 
includes moderate to severe pain, suspected organic problem, failure to respond to non-
controlled substances, adjuvant agents, physician ordered physical therapy, structured exercise 
program, and interventional techniques. Every therapy needs to be evaluated for effectiveness. 
The guidelines suggest looking at the effectiveness and the side effects, being careful with high 
doses of long-acting opioids, considering trial of opioid rotation, and also looking at possible 
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opioid contraindications. Patients need to be aware of the risks and benefits of initiating opioid 
therapy (Manchikanti, 2012). 
 To initiate treatment, the guideline recommends performing a stratification of risk to 
prevent misuse or abuse and to categorize the patient into low, medium, or high risk. Patients 
need to be started on the lowest dose possible and titrated gradually to higher dosages, if 
necessary. Once therapy is started, adherence monitoring and managing side effects are 
important for a provider to monitor and reassess to determine if opioid treatments need to 
continue. Accurate and complete documentation must be performed, including all aspects of pain 
characteristics and management (Manchikanti, 2012). 
CDC Guidelines for Prescribing Opioids for Chronic Pain 
 The Centers for Disease Control and Prevention (CDC) published updated guidelines for 
prescribing opioids for chronic pain and their recommendations are geared towards primary care 
providers. Twelve recommendation statements were written and addressed when to initiate or 
continue opioids for chronic pain, opioid selection, dosing, duration, follow-up, and 
discontinuation, and also assessing risk and addressing harms of opioid use. The CDC performed 
a systematic review of the scientific evidence to base their recommendations on in combination 
with input from experts and stakeholders (Centers for Disease Control and Prevention, 2016).   
 Statistics from the CDC further emphasize the prevalence of opioid abuse in the United 
States. According to the CDC published guidelines (2016), “an estimated 20% of patients 
presenting to physician offices with noncancer pain symptoms or pain-related diagnoses 
(including acute and chronic pain) receive an opioid prescription” (p. 1). Opioid prescriptions 
increased by 7.3% from 2007 to 2012. A study showed that 11.2% of adults report daily pain and 
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having chronic pain can cause clinical, psychological, and social consequences (Centers for 
Disease Control and Prevention, 2016).  
 The CDC guidelines outlined three recommendations related to the initiation and 
continuation of opioids for chronic pain. Nonpharmacologic therapy and nonopioid 
pharmacologic therapy are the preferred treatment options for chronic pain. Opioids should only 
be considered if the benefits outweigh the risks. If deciding to start opioid therapy, treatment 
goals should be established and focused on realistic pain and function levels. How the therapy 
will be discontinued should also be discussed at the time of initiation (Centers for Disease 
Control and Prevention, 2016).  
 Before beginning opioid therapy and periodically throughout the therapy, clinicians 
should discuss with patients the known risks and benefits of opioid therapy. Patients and 
clinicians also need to discuss each parties’ responsibilities in regards to the treatment plan 
(Centers for Disease Control and Prevention, 2016).  
 The CDC wrote four recommendation statements regarding the selection of opioids, 
proper dosing, reasonable duration, and follow-up and discontinuation plans. In regards to opioid 
selection, immediate-release opioids should be used instead of extended-release or long acting 
opioids. The lowest effective dose should be prescribed and always be used with caution, 
regardless of the dose. Clinicians should avoid increasing the dose to greater than 90 morphine 
milligram equivalents a day (Centers for Disease Control and Prevention, 2016).  
 Acute pain can often lead to long-term opioid use. Clinicians treating acute pain should 
prescribe the lowest effective dose possible and shortest duration possible, three days is typically 
sufficient. For chronic opioid users, clinicians should be evaluating them at least every three 
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months. If benefits are not outweighing the risks, other therapies should be optimized and 
opioids should be tapered down (Centers for Disease Control and Prevention, 2016).  
 Opioid therapy has many potential risks and can be dangerous to patients, even leading to 
death. Before and during therapy, risk factors for opioid-related harms should be evaluated. Extra 
caution should be used in patients that have a history of overdose, history of substance use 
disorder, higher opioid dosages, or concurrent benzodiazepine use. The CDC recommends the 
use of the PDMP to evaluate for dangerous combinations or receiving excess opioids. The 
PDMP should be checked with every prescription or at least every three months (Centers for 
Disease Control and Prevention, 2016).  
 Another safety recommendation includes avoiding the concurrent use of opioids with 
benzodiazepines whenever possible. If patients have opioid use disorder, evidence-based 
treatment plans should be offered or arranged (Centers for Disease Control and Prevention, 
2016).  
 This guideline provides evidence-based recommendations for primary care providers 
treating patients for chronic pain. The CDC recommends using extra caution when treating 
chronic pain with opioids and stresses that opioids are not first-line therapy for chronic pain. 
Ideally this guideline will lead to safer opioid prescribing and maybe decrease the amount of 
opioid prescriptions written nationwide. 
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CHAPTER THREE. THEORETICAL FRAMEWORK 
Iowa Model of Evidence-Based Practice  
 Healthcare management, policies, and protocols are developed based on evidence-based 
practice. Evidence-based practice is defined as “the use of reliable, explicit, and judicious 
evidence to make decisions about the care of individual patients, combining the results of well-
designed research, clinical expertise, patient concerns, and patient preferences” (Doody & 
Doody, 2011, p. 661). The Iowa model focuses on knowledge triggers, questions current 
practices, and considers improving practice through current research findings. The Iowa model 
involves seven steps, from selection of a topic to evaluation.  
Selection of a Topic 
 Selection of a topic should consider the priority of the problem, apply to a variety of 
areas, contribute to improving care, and be supported by evidence related to the problem (Doody 
& Doody, 2011). Managing chronic pain patients receiving opioid pain medications requires 
frequent assessments and monitoring. Adequate monitoring of chronic pain can improve the care 
of patients and potentially prevent many complications. A thorough literature review regarding 
this topic produces a large amount of research articles.  
Forming the Team 
 The team is responsible for development, implementation, and evaluation (Doody & 
Doody, 2011). Members possess interest in the current topic. This project’s team includes a 
chair, three committee members, and a graduate school appointee. The chair and three committee 
members on the team are all opioid-prescribing nurse practitioners and have professional 
experience to contribute to this topic. The graduate appointee is a member of the College of 
Pharmacy who has expertise in statistical analysis and economics.  
 
 
20 
Evidence Retrieval and Grading the Evidence 
  Based on the topic and recommendations from committee members, evidence was found 
using electronic databases as mentioned above. Topics searched included opioid screening tools, 
opioid abuse, pain management protocols, opioid abuse risk factors, and monitoring programs 
for patients at risk for opioid abuse. The evidence retrieved includes both qualitative and 
quantitative data. Criteria for evidence included date of publication being recent and from a valid 
and trusted source.  
Developing and Implementing Evidenced-Based Practice 
 The goal of the project was to develop an evidence-based systematic process of 
monitoring patients with chronic pain. The project was designed to assist providers with patient-
centered care in regards to pain management. Providing documentation tools and best practice 
flow sheets within the electronic health record were developed in order to provide a user-friendly 
tool for providers caring for chronic pain patients. Partnership is encouraged for safe pain 
management, such as with the use of a pain contract between patient and provider.  
 Implementation of the project began with collaborating with the healthcare organization’s 
computer information systems department to create a pain visit template and chronic pain flow 
sheet. Once those tools were created, the project leader inputted the data based upon a chart 
review of known chronic pain patients to assist providers on managing these patients when they 
present to the clinic along with informing them of what patients are lacking identified elements 
of safe and effective chronic pain management.   
Evaluation 
 Evaluation is essential to the theoretical framework in order to see the contribution of the 
evidence to practice and evaluation of this project involves two parts both at the initial 
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implementation and at the six-month follow-up. The initial phase occurred with the 
implementation and data entry to determine what the chronic pain patient population is lacking in 
regards to monitoring. The second phase was a chart review at the six-month follow-up to 
determine if that same patient population’s chronic pain monitoring and adherence improved and 
also a survey of the providers to determine if they felt the pain visit templates and chronic pain 
flow sheets were of benefit to their practice and if they foresee use of these tools in the future.  
The Trajectory Model 
 The theory used to guide this project is a middle-range nursing theory known as the 
Trajectory Model. The Trajectory Model was developed by Anselm L. Strauss, a medical 
sociologist, and Juliet Corbin, a nurse theorist. After over 30 years of interdisciplinary research 
on a variety of chronic illnesses, this model was created. The trajectory considers the course of 
the chronic illness along with the actions taken by health professionals and patients in managing 
the disease (Corbin & Strauss, 1991).  
 The Trajectory Model not only focuses on the work of the individual, but also suggests 
collaboration between the patient and provider. Goals for pain management are set 
collaboratively with any uncertainties being addressed and establishing a trust between the 
provider and patient. These steps are recommended for enhancing the aforementioned 
collaboration with attempts to improving the overall trajectory (Granger, Moser, Harrell, 
Sandelowski & Ekman, 2007).   
 Chronic pain is considered a chronic disease. The Trajectory Model is applicable to the 
chronic pain population and their adherence to their individual management plan. An 
individual’s ability to manage their condition takes work. For example, chronic pain patients are 
required by the provider treating their chronic pain to fill their prescriptions, attend follow-up 
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appointments, provide urine drug screens, and possibly participate in other pain adjuncts, such as 
physical therapy or cognitive behavioral therapy. The model was utilized to improve the 
understanding of chronic pain patients and provide the patient’s perspective on their individual 
chronic disease process. Below is a visual representation of the Trajectory Model applied to 
chronic pain. 
 
Figure 1. The Trajectory Model 
Congruence of the Project to the Organization’s Strategic Plan/Goals 
 The regional health system values honest communication, collaboration for superior 
patient care and provide service to meet the emotional, spiritual, and physical needs for their 
Pre-
Trajectory
• Past life history
• Onset of pain 
• Due to injury, surgery, chronic illness, or idiopathic
Trajectory 
Onset
• Chronic Pain diagnosis
• Seeking support
• Collaborating with provider for chronic pain management
Living with 
Chronic Pain
• Symptom burden
• Enduring treatments (surgery, injections, opioid therapy)
Downward 
Trajectory
• Acute episodes of breakthrough pain
• Opioid dependence, side effects, hyperalgesia
• Possible display of aberrant behavior
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patients. The regional health system network where the project was implemented consists of 
several rural clinics providing comprehensive patient care; including chronic pain management. 
The participating clinic aims to provide chronic pain management that is safe and effective. The 
participating clinic hopes to better utilize the electronic health record in order to provide more 
efficient care to their many chronic pain patients as they do not currently possess an in-network 
pain clinic. 
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CHAPTER FOUR. PROJECT DESIGN 
 This practice improvement project started with determining the need of a chronic pain 
monitoring and documentation tool within the electronic health record in a rural primary care 
clinic. The project leader met with a nurse practitioner from the clinic on February 3, 2016. The 
nurse practitioner reports that a large percentage of the patient population seen at the clinic are 
chronic pain patients and himself and the other two providers, find difficulty monitoring this 
particular population. These patients are managed at this rural clinic, as a specialized pain clinic 
does not exist within network and referrals to outside facility are not always feasible based on 
patient’s schedules, long wait-lists at the clinics, psychosocial background, and transportation 
issues.  
 The clinic and larger healthcare system the clinic falls under uses AllScripts for their 
electronic medical record. Based on the current desktop and available templates for charting 
office visit notes, the project leader in collaboration with Hohman determined that a chronic pain 
flow sheet along with a pain visit template had the greatest potential to provide benefit in caring 
for this patient population.  
 The flow sheet was made easily accessible from the patient’s chart desktop. Elements of 
the flow sheet were beneficial to chronic pain patients and in congruence with evidence-based 
practice. These elements included dates of last pain contract signed, prescription monitoring 
program checked, last urine drug screen, and last pain visit. A pain visit template was added to 
the office visit note and contained a combination of the Brief Pain Inventory (Appendix E), a 
pain assessment filled out by the patient prior to the start of the visit, and the 4 A’s of chronic 
pain, which include analgesia, activity, adverse effects, and aberrant behaviors. The tools were 
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created in collaboration with the computer information services (CIS) team at the healthcare 
organization.   
 The project leader sought approval and chart access through the human resources 
department by completing background checks and providing any requested information. The 
providers at the clinic were sought after for approval to use the flow sheet in a percentage of their 
chronic pain patients.  
 Following approval of the proposal and the Internal Review Board, implementation of the 
project began. Implementation involved surveying the three providers (including a physician, 
nurse practitioner, and physician’s assistant) regarding their current practice of caring for chronic 
pain patients. The providers along with nurses received notification that the pain visit template 
was available along with how to update information in the flow sheet after the writer performed 
the initial data input.  
 The majority of the project implementation entailed the project leader taking the provided 
sample set (a percentage of chronic pain patients seeking care at the clinic) and assessing what 
elements the patients were lacking and inputting the dates into the created flow sheet. Specific 
statistical data and information regarding chronic pain patients’ needs were given to the 
providers and nursing staff. 
 After a six-month timeframe, a chart review of the exact same patients in the sample was 
performed to assess if a greater percentage of the elements were present, if the flow sheet was 
manually updated, and if the pain visit template was utilized. A follow-up survey was again 
delivered to the three providers. 
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Timeline of Project Phases 
February: 
• Key informant interview with nurse practitioner from the clinic  
• Meeting with CIS department 
• Design of Pain Visit Template and Chronic Pain Flow Sheet in collaboration with 
CIS  
• Obtain chart access through human resources department 
March:  
• Memo of Understanding and Agency Letter of Agreement signed by lead physician 
• Proposal Meeting 
April:  
• IRB Approval 
May: 
• Provider surveys/interview with the providers   
• Meeting with the CIS department 
June: 
• Initial chart review and data input 
August: 
• Halfway point check-in 
December: 
• Chart review and data collection 
January:  
• Dispensed post-implementation surveys 
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March 2017:  
• Final dissertation written 
• Dissertation defense 
Resources 
 Resources for this project included providers, nurses, and CIS specialists from the clinic 
and healthcare organization. Technology resources included remote access to the electronic 
health record and approval to use this access from the human resources department. No financial 
resources or outside funding was required to implement this practice improvement project. 
Protection of Human Subjects 
  The practice improvement project entailed virtually no risk to patients as the project did 
not involve any direct contact with patients. Patient medical records were accessed using a 
secure log in and information was not shared with any other parties. Data collection was done in 
a way that patients were not identifiable within the data collection record. No HIPPA violations 
occurred during this practice improvement project.   
 The potential benefits of this project largely outweigh the risks. This practice 
improvement project aimed to improve the safety of opioid prescribing and monitoring of 
chronic pain patients. Important knowledge gained from this project was identifying current gaps 
in chronic pain patients seeking opioids at a rural clinic and providing tools to decrease those 
gaps in practice.  
Institutional Review Board Approval  
 Approval for protocol #PHI16232 was received from the North Dakota State University 
Institutional Review Board (Appendix D). The surveying of the providers fell under the exempt 
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category for IRB approval. The chart review and data input portion of the project fell under the 
expedited category #5.  
Methods 
  A meeting was held with the providers at the clinic. The meeting began with the 
providers completing the survey (Appendix B) followed by an open discussion regarding the use 
of opioids and the monitoring of opioid prescriptions within their current practice.  
 The project leader reviewed all the current pain visit templates available within the All 
Scripts electronic charting system. After reviewing the templates, provider preference, and the 
research on the documentation requirements for chronic pain visits, a rough draft pain visit 
template was designed. After discussing with members of the CIS team about the capabilities of 
having a chronic pain flow sheet, a chronic pain flow sheet was designed. Elements of the flow 
sheet was determined by the published evidence-based guidelines stating the recommended 
parameters to monitor in chronic pain patients.  
 With the creation of the pain visit templates and chronic pain visit rough drafts, the 
project leader along with committee member, Adam Hohman, DNP, met with the CIS 
department. The CIS department was able to collaborate with the project leader and within one 
week, produce the pain visit template and chronic pain flow sheet and make it available for the 
clinic providers to use within the electronic medical record.  
 The next step of the project was performing the initial chart review and inputting the data 
into the flow sheet. The sample for this project included adults aged 18 years and older seeking 
chronic pain management from the designated clinic. The patients were selected primarily from 
the use of the Minnesota Prescription Drug Monitoring Program Database. The sample size 
totaled sixty-one patients. Patients were assigned a number in order to maintain confidentiality.  
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 Approximately one month following the initial data input, the project leader touched base 
with the providers to ensure they were aware of how to make use of the flow sheet and the pain 
visit template. Questions and concerns were addressed at that time.  
 Six months after the initial chart review and data entry, a final chart review was 
performed of the same original sample. Monitoring parameters were compared to see if chronic 
pain patients were more closely monitored and recommended documentation was in place. 
Providers were issued another survey (Appendix C) that resembled the initial pre-
implementation survey and also asked questions regarding their use of the flow sheet and pain 
visit template.  
 
Figure 2. Example of the Chronic Pain Flow Sheet 
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CHAPTER FIVE. EVALUATION 
 The evaluation plan for this project involved individually evaluating the objectives.  
Evaluation of Objective One 
 The first objective was to assess the providers’ perception of their current chronic pain 
management process in regards to usability, efficiency, and overall comfort level in caring for 
the chronic pain patient population. Objective one was evaluated based on surveys administered 
to the three providers at the clinic during the initial implementation of the project and at final 
review of the project. Comparisons of the survey were made to determine if this project 
improved providers’ comfort level in regards to safe opioid prescribing practices and made the 
monitoring of their chronic pain patients easier and more comprehensive. See Appendix B and C 
for pre and post-implementation provider surveys.  
Evaluation of Objective Two  
 The second objective was to create and implement evidence-based chronic pain 
documentation and monitoring tools to be used within the electronic health record. Tools 
included a template to be used when documenting a pain visit along with a flow sheet to easily 
monitor important parameters of chronic pain patients. Objective two was evaluated by 
determining the presence or absence of the elements of chronic pain management in the patient 
sample. These statistics were taken at the initial phase of the project implementation and 
compared to a six-month chart review. The project leader aimed for the final evaluation to show 
a higher percentage of elements were completed on the sample of chronic pain patients. The six-
month chart review also revealed if the template was utilized and the flow sheet updated 
appropriately. Another piece of evaluating this objective was performed via a questionnaire to 
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the providers simply asking if the created tools were useful and beneficial to practice (see 
Appendix C).  
 
Figure 3. Logic Model 
  
Inputs
• Clinic Providers & CIS department
• Chronic Pain Patients 
• NDSU DNP Student & Committee
• CDC Chronic Pain Guidelines
Activities 
• Determined need for chronic pain monitoring at rural primary care clinic 
through surveys and discussion
• Designed and developed chronic pain flowsheet and pain visit template to 
use within the electronic medical record
• Educated staff on use of the available tools within the electronic health 
record
• Evaluated project with post chart review and post-implementation survey
Outputs
• Chart review showing improvement in presence of pain contract and 
decrease in presence of PDMP, UDS, and pain visit
• Post implementation survey showing continued difficulty with chronic 
pain patients but motivation and interest in improving monitoring and 
utilization of available tools
Short Term 
Outcomes
• Providers find the chronic pain flowsheet and pain visit template helpful 
and user-friendly 
• Chronic pain patients are meeting the key monitoring parameters
Long Term 
Outcomes
• Monitoring tools lead to improved safety of chronic pain patients and 
continued to be utilized 
• More of the clinics withint the healthcare organization using the flowsheet 
and template
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CHAPTER SIX. RESULTS 
 The practice improvement project involved analyzing two aspects of chronic pain 
monitoring in patients receiving care at the designated rural clinic. The first was collecting 
qualitative data regarding the providers’ current perception of their chronic pain patients and the 
monitoring of their care and how that perception may have changed after the implementation of 
this project. The second part of this project was the design and implementation of a chronic pain 
flow sheet and pain visit template. Using evidence-based research, the project leader determined 
the important monitoring parameters of patients with chronic pain and performed an initial chart 
review and inserted the data into the flow sheet. The project leader then performed a six-month 
chart review to determine if the monitoring parameters were met and if there was an overall 
improvement in the monitoring of chronic pain patients.   
Pre-Implementation Provider Survey Results 
 A pre-implementation survey (Appendix B) was dispensed to the three providers at the 
clinic on May 31, 2016. An open discussion was held after the survey portion was filled out 
between the project leader and the providers.  
 The first question of the survey asked about the current level of satisfaction with the 
monitoring of chronic pain patients and providers responded based on a scale from 1-5, with 5 
being extremely satisfied and 1 being not at all satisfied. One provider felt slightly satisfied 
(score of 2) and the other two felt moderately satisfied (score of 3).  
The second question was of multiple parts, asking providers to answer the questions in a 
form of a percentage, based on their current chronic pain patients having certain parameters in 
place. Two providers felt 60-80% of their patients had a signed pain contract within the last year, 
one provider felt only 41-60% had a contract. Two providers thought 61-80% of their chronic 
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pain patients had a urine drug screen performed within the last six months, and one provider felt 
21-40% of his/her patients had this performed. Two providers felt that 0-20% of their patients 
had their pharmacy drug monitoring program checked with the last pain prescription, and one 
provider felt 21-40% of their patients had their PDMP checked with the last prescription. When 
asked if a patient had a pain visit within the last 3-4 months, two providers felt 61-80% of their 
patients had a pain visit within that time frame and one provider felt 81-100% of his patients met 
this criterion.  
The third question of the survey targeted the providers’ feelings regarding the electronic 
health record (EHR) and its usability for searching for monitoring elements of chronic pain 
patients. This question was answered on a scale from not at all to extremely user-friendly. One 
provider felt the EHR was not easy to use at all, one provider felt it was slightly user-friendly, 
and the last provider felt it was moderately user-friendly. The fourth question asked how the 
providers document pain visits and options included: free text, dictate, use a template, every 
patient is different, and other. Two providers chose dictate and one provider chose free text. 
The fifth question of the survey asked providers about their current level of satisfaction in 
regards to the system’s ability to allow for pain visits to be easily documented and ensure they 
cover all the necessary elements of pain assessments (analgesia, activities of daily living, adverse 
effects, aberrant behaviors, and affect). One provider felt not at all satisfied with the system and 
two providers felt only slightly satisfied with the current system. 
The final three questions of the survey were open-ended and allowed for individual 
answers and opinions. Question six simply asked, “What is going well currently with your 
chronic pain management in your practice?”. Answers included, “using forms from paper 
charts”, “dictating notes”, and “printing Rx’s”. One provider said, “we are decreasing the amount 
 
 
34 
of people and dosages on many of the patients” and also mentioned “using PT, massage, topicals, 
etc. instead”.  
The seventh question of the survey inquired about the barriers and concerns providers 
have with chronic pain management in their practice. Providers responded with “vague structures 
from regulating agencies”, “EHR issues”, and “lack of consultants to review patients needs and 
care plan”. Other barriers or concerns mentioned were “no good tracking system here with 
prescriptions- Sanford has prescription monitoring where they are automatically generated 
monthly and tracked by a nurse”, “finding data in EHR pertaining to pain visit”, and “charts 
being flagged as pain contract present”.  
The final question on the survey that led to open discussion was “what other comments 
do you have?”. Providers mentioned frustrations with having no second opinion available 
regarding their chronic pain patients, guidelines being difficult to follow and treat patients 
accordingly, and feeling that the practice of treating chronic pain is difficult. Providers also 
mentioned the change in practice over the past twenty years. For example, twenty years ago 
providers were encouraged to push medications and if a provider did not treat pain, they were 
considered a bad provider. Now, regulatory agencies are enforcing providers to reduce or stop 
opioids at all costs. One provider stated “a flow sheet would be very helpful”.   
Results of Initial Chart Review 
 During the month of June, the project leader performed an initial chart review of 61 
chronic pain patients seeking treatment at the clinic. Data collected on each patient included pain 
contract signed and filed within the last year, last prescription drug monitoring program checked, 
last urine drug screen, and last pain visit. Data analysis was performed to determine the 
percentage of patients that met each parameter along with determining how many patients met 
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multiple parameters. Patients were assigned a number that is not-identifiable and no 
demographic information was collected.  
 Data analysis on the presence of a pain contract signed and filed showed that 24.59% of 
patients did have a signed contract within the EHR. Of that percentage, 19.67% had a contract 
that was done within the last 12 months. Fifty-five point seventy-four percent of patients did not 
have an electronically filed pain contract but did possibly have a paper chart copy. The 
remaining patients either did not have a pain contract at all (11.48%) or required an updated 
contract (8.20%), meaning there was not a paper copy or the contract was void since it was not 
the most recent pain contract version.  
 Next, the project leader looked at whether or not the prescriber checked the prescription 
drug monitoring program. This statistic is limited in the fact that unless the provider charted that 
they checked the PDMP, the project leader assumed it was not checked. Research showed that 
22.95% of patients had their PDMP checked and it had been done within the last six months. 
However, over three-fourths (77%) of charts showed the prescriber never checked the patient’s 
PDMP. 
 Ideally, urine drug screens are completed on chronic pain patients every six months. The 
project leader’s initial chart review revealed 36.1% of patients had a urine drug screen on record, 
and 26.2% of patients had a urine drug screen performed within the last six months. The majority 
of patients (63.9%) had no urine drug screen on file.  
 Pain visits were present in the majority of chronic pain patients and 72.1% were done in 
the last four months. However, 3.3% of chronic pain patients did not have a documented pain 
visit.  
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 As stated above, guidelines and regulatory agencies recommend that all of the measured 
parameters be met in every chronic pain patient to ensure treatment is done safely and efficiently. 
Criteria used for this data analysis included: pain contract within the last 12 months, PDMP 
within the last six months, UDS within the last six months, and pain visit within the last four 
months. Data analysis revealed that only 8.2% of chronic pain patients met all four parameters, 
11.5% met three parameters, 16.4% met two parameters, 44.3% met one parameter, and 19.7% 
did not meet any of the monitoring parameters.  
Post-Implementation Provider Survey Results 
 A post-implementation survey (Appendix C) was distributed to the providers at the clinic 
on January 12, 2017. After the surveys were dispensed, an open forum discussion took place. 
Providers were also informed of the results of the data analysis from the chart review, as 
described in the next section.  
 The following graphs (Figures 4 and 5) show the comparison of the survey questions 1, 2, 
3, and 5. 
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Figure 4. Survey Results: Questions 1,3,5 
 
Figure 5. Survey Results: Question 2 
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The fourth question asked how the providers document pain visits and options included: 
free text, dictate, use a template, every patient is different, and other. One provider chose free 
text, one chose dictate, and the last provider chose using a template.  
Question six simply asked, “What is going well currently with your chronic pain 
management in your practice?”. Answers included, “utilizing chronic pain flow sheet to track 
patients and patients’ cooperation with contract”. One provider responded with “nothing got 
easier with the electronic health record”. Other responses included “weaning people off”. This 
provider also stated “I do not have many and they have done everything I have asked and are 
compliant”.  
The seventh question of the survey inquired about the barriers and concerns providers 
have with chronic pain management in their practice. Providers responded with “non-
compliance, selling instead of taking”. Other barriers or concerns mentioned were “regulators” 
and “lack of my accountability to get patients in for appointments along with difficulty getting 
patients into pain clinic at times due to long visits”.  
The eighth question on the survey asked about the frequency of use of the chronic pain 
flow sheet on a scale of never to every time. One provider selected every time, one selected 
never, and another selected almost never. The ninth question asked about the frequency of the 
use of the pain visit template. Responses included never, almost never, and almost every time (if 
started by nursing at the beginning of the visit). The tenth question asked about the likelihood of 
continuing use of the flow sheet and template on a scale of extremely unlikely (1) to extremely 
likely (5). Two providers were neutral in responding to this question and the third provider 
responded as being extremely likely to continue the use of the designed tools.  
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The survey asked for suggestions on how to make the flow sheet and pain visit template 
more efficient and user-friendly. One provider suggested, “have EHR built in to auto populate 
some of the info”. Another provider simply stated “big big task”.  These comments suggest 
providers feel overwhelmed with monitoring chronic pain patients and feel their EHR could help 
with this task. The final question of the survey asked for any comments providers have. 
Comments included “need to do better job on my part of re-emphasizing to nurses to use 
template”, and “it is difficult to separate pain treatment from non-pain care”.  
After the surveys were completed and data analysis results shared, the providers and 
project leader discussed chronic pain patients, the monitoring tools within the chart, and areas for 
improvement. One of the biggest barriers identified was seeing a patient solely for their pain 
visit. Often patients come in for their multiple chronic diseases and at the same time, their 
chronic pain is addressed. One of the providers suggested a policy change that requires patients 
to come in for a pain visit and patients are under the understanding that they can only discuss 
their chronic pain at that visit. 
 Ideas were discussed on ways to improve the overall monitoring process such as 
involving pharmacists in checking the PDMP and utilizing nursing staff more for tasks such as 
checking the PDMP and updating the out of date pain contracts. Also, providers mentioned 
changing their own habits in ensuring they are documenting when they check the PDMP and also 
updating the information within the flow sheet. Providers also requested printed out instructions 
in the room as to how to implement the flow sheet and template within their patient’s chart.  
Overall, providers appeared motivated to improve the monitoring of their chronic pain 
patients and to take advantage of the tools available to them within the electronic health record. 
Time is always an issue for busy primary care providers, so working on making the 
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documentation of these elements a habit, along with delegating to appropriate parties for help, 
could increase the percentages of patients meeting all the required parameters. In the end, the 
providers admitted “I need to start using it, I need to get better”.  
Results of Final Chart Review 
 Approximately six months after the initial chart review was performed and the chronic 
flow sheet was made available within the electronic health record, the project leader performed a 
final chart review using the same panel of chronic pain patients. This post chart review aimed to 
see that these identified chronic pain patients at the clinic possessed the recommended 
monitoring parameters in their medical record.  
 During the month of December, the project leader determined if the patients had a signed 
and filed pain contract within the last 12 months, the prescription drug monitoring program 
checked within the last six months, a urine drug screen within the last six months, and finally, if 
a documented pain visit was performed within the last four months.  
For the initial chart review, the sample size was 61 chronic pain patients. For the final 
chart review, the sample size decreased to 52 chronic pain patients. The decreased sample size is 
due to patients’ chronic pain contract (and prescription of opioids) being discontinued for various 
reasons. Reasons included mental health disorders, terminal illness, inappropriate urine drug 
screens, and safety concerns related to elderly and chronic opioid use.  
Data analysis on the presence of a signed and filed pain contract within the last 12 
months showed 25% of chronic pain patients met this criterion. The remaining 75% of the 
chronic pain patients either had an outdated pain contract or did not possess a pain contract that 
was visible within the electronic health record. During the initial chart review, 19.67% of chronic 
pain patients had a pain contract signed and filed within the last 12 months. Therefore, the clinic 
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saw a 5.33% increase in chronic pain patients possessing a valid pain contract within the medical 
record.  
The next parameter measured determined if the PDMP was checked within the last six 
months. This data was retrieved by looking at the chronic pain flow sheet and/or looking at the 
last pain visit to see if the provider documented checking the PDMP. In reviewing the charts, the 
project leader found 11.5% of chronic pain patients had their PDMP checked within the last six 
months. The resulting percentage dropped from 22.95% during the initial chart review. The 
remaining 88.5% of patients had no documentation within their medical record that the PDMP 
had ever been checked or greater than six months had passed. 
Guidelines recommend checking a urine drug screen every six months. To determine if 
this testing was done on the project sample, the project leader referred to both the chronic pain 
flow sheet and the lab results. The results showed 21.2% of patients completed a urine drug 
screen within the last six months. In comparing those results to the initial chart review, the 
sample showed an approximate 5% decrease in patients meeting the six months’ criteria for 
UDS.  
The final parameter determined if a pain visit was performed within the last four months. 
Data analysis revealed 69.2% of patients met this criterion. This data was collected by checking 
both the chronic pain flow sheet and looking through the medical record at previous visits. 
Analysis from the initial review and comparing the results to the final review show a 2.9% 
decrease in chronic pain patients having a pain visit within four months.   
As performed in the initial chart review, the project leader again determined how many of 
the four identified parameters each patient met. Four of the fifty-two patients met all four 
parameters, or 7.7% of the sample population. Three parameters were met in 5.8% of the sample 
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population, 19.2% met two of the parameters, and 46.2% of the population met only one 
parameter. A total of 11 patients, or 21.2%, did not meet any of the monitoring parameters.  
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CHAPTER SEVEN. DISCUSSION AND RECOMMENDATIONS 
 The results of the practice improvement project show the importance and the necessity of 
monitoring and documenting tools in regards to care of the chronic pain patients at the rural 
clinic. However, based on the chart review statistical analysis of the data, the developed chronic 
pain flow sheet was not as effective as anticipated by the project leader. One provider was very 
actively involved in this project and seemed to utilize the tools created more than the other two 
providers. The survey does show providers feel the need to improve the monitoring of their 
chronic pain patients and see the potential benefit in better utilizing the flow sheet and template.  
Project Limitations 
 After designing, implementing, and evaluating the practice improvement project, the 
project leader identified several limitations of the project. The pain visit template was designed 
to make the electronic health record more user-friendly in the documentation of pain visits and 
allow for the provider to easily assess and document all the areas of chronic pain management.  
Chart review and provider discussions revealed the pain visit template was only utilized if the 
nursing staff opened the note prior to the provider seeing the patient. More education with 
nursing staff regarding how and when to open a patient’s chart with the pain visit template may 
have improved template utilization.   
 The provider dissatisfaction with the electronic health record is not unique to the 
healthcare organization utilized in the project. A survey of 146 primary care providers regarding 
the “meaningful use” of the electronic health record showed overall dissatisfaction and 
suboptimal use of the key functions of the EHR. The study showed large potential for 
improvement in regards to reliability and accuracy of the EHR and helping providers use their 
time more efficiently (Makam et al., 2013).  
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The chart review information primarily came from reviewing the chronic pain flow sheet. 
The data input needed to be done manually in the chronic pain flow sheet. For example, a date 
may not have been updated in the flow sheet for the last PDMP checked, but the check was truly 
done, the provider simply did not input the new date. Another consideration is that the flow sheet 
and the information requested may simply have been used as a reminder for providers. Although 
the data was not updated, it may have been queuing providers to ensure they were checking those 
important elements. 
 Another limitation for this project is the fact that all patients are unique, and chronic pain 
patients are no exception. It may not be possible for all patients to meet all the recommended 
monitoring parameters. For example, a chronic pain patient with chronic kidney disease may 
have difficulty providing a urine sample. Also, chronic pain patients typically have other co-
morbidities. So, it may appear that a pain visit was not performed, even if their chronic pain was 
addressed in combination with several other chronic health problems.  
 Providers can perform many interventions on their end to ensure safe and effective 
chronic pain management. However, the patients also need to take an active role in their care. 
Unfortunately, sometimes patients do not follow-up or comply with the recommendations to be 
seen frequently. Due to lack of follow-up, this may be seen as a limitation for this project and 
result in lower than expected data analysis results.  
 A final consideration for this project may be the difference in providers and possibly 
generational characteristics. As stated above, it was once thought that a provider was considered 
“bad” or “negligent” if he/she did not adequately treat their patient’s pain. What was once 
considered “the fifth vital sign” has turned into an area that needs careful consideration to avoid 
detrimental consequences. Not only do viewpoints of pain management differ among the 
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generations of providers, so does the comfort level with technology. Seasoned providers may not 
feel as comfortable with new tools within the electronic health record or take less of an initiative 
to change their current documentation practices.  
 Limitations of this project were anticipated due to the magnitude of the task at hand. 
Opioid abuse and chronic pain are difficult for primary care to manage, not only at the 
designated clinic but primary care practices around the country. A study was conducted on a 
select group of primary care providers in the Boston metro area to determine presence of benefits 
of interventions to track compliance with opioid medications prescribed to patients with non-
cancer chronic pain. Patients were monitored on a monthly basis via a telephone call and 
providers were given questionnaires regarding their chronic pain practice (Jamison, Scanlan, 
Matthews, Jurcik, & Ross, 2016).  
Despite these monthly monitoring interventions on patients and opioid education for 
providers, many primary care providers remained concerned about opioid addiction and 
dependence but did feel pleased their patients were closely monitored. Patients did have better 
compliance with their opioid medication and felt the monthly monitoring was beneficial. Overall, 
providers felt chronic pain patients were stressful to deal with. Results of this study, similar to 
those of the described practice improvement project, show need for continuing education for 
primary care providers and close monitoring of chronic pain patients (Jamison, Scanlan, 
Matthews, Jurcik, & Ross, 2016).  
Recommendations for Project Site 
 Despite data analysis not showing improvement in chronic pain monitoring parameters, 
the project leader recommends this project be continued at the rural clinic and expand to the 
larger healthcare system. Further education needs to occur on both the nursing and provider level 
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to improve the usage of the pain visit template and chronic pain flow sheet. Collaboration with 
the CIS department may improve compliance with the chronic pain flow sheet by finding a way 
to allow the fields of the chronic pain flow sheet to be automatically filed. For example, any time 
a urine drug screen is resulted for a pain patient that has a chronic pain flow sheet open within 
the chart, the date of the drug screen is automatically inputted into the flow sheet. A 
multidisciplinary approach has the greatest potential for reaching the desired outcome of 
improved chronic pain monitoring.  
 Despite the data analysis not showing overwhelming improvement in chronic pain 
monitoring, the project leader does think the pain visit template and chronic pain flow sheet have 
the potential to help primary care providers manage their chronic pain patients. Because these 
tools were developed within AllScripts, the tools are available to not only the rural clinic, but the 
entire healthcare network. This project has the potential to positively impact the practice of 
several providers and may result in a network-wide improvement in the management of chronic 
pain patients. Considering opioid abuse and chronic pain is at the forefront of medicine and 
considered a national priority to reduce its negative effects, primary care providers may find it 
imperative and beneficial to utilize the tools created. 
 The project leader suggests the clinic continues this project and expand its usage through 
further education and guidance. The provider that was very familiar with the available tools 
should create “cheat sheets” for the other providers to show them how to access the available 
tools within the electronic records of their chronic pain patients. Also, nursing staff should be 
educated in these interventions and be delegated to seek out updated pain contracts for patients. 
Nursing staff may also be given delegate access to check the PDMP and provide open 
communication among nursing staff and providers.  
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 Incentives for providers at the clinic to continue this project include mandates derived 
from the state level. In March of 2016, Minnesota developed the Opioid Prescribing Work Group 
to reduce opioid dependency and substance use by Minnesotans. Tasks set forth by this group 
include recommending protocols that address all phases of the opioid prescribing cycle, 
improving providers’ education on use of opioids, and implementing quality-improvement 
measures in clinical practice (Minnesota Department of Human Services, 2016). 
 Whether continuation of this quality improvement project or implementing new quality 
improvement projects, future project leaders can take steps to improve health behavior 
interventions in a primary care setting. The following recommendations derived from a study 
conducted through the Robert Wood Johnson Foundation’s Prescription for Health. The first step 
is for the project leader to have a better understanding of the practice’s organization. Secondly, 
collaborating with the multidisciplinary team can help clinicians identify patients who need 
change and assist clinicians in working towards that positive change. Lastly, the project leader 
should include a goal of implementing long-term and sustainable quality improvements (Cohen, 
Tallia, Crabtree, & Young, 2005). 
Implications for Practice and Future Research 
 Results of this practice improvement project were disseminated to multiple audiences in 
various forms. A poster presentation with available data analysis statistics was presented at the 
North Dakota Nurse Practitioner Association Pharmacology Conference in September 2016. The 
project leader also wrote and delivered a three-minute synopsis of the project to a non-healthcare 
audience during the Three Minute Thesis Competition held at North Dakota State University in 
February 2017.  A final poster was also created by the project leader and presented at the Health 
Professions poster presentations in March 2017 at North Dakota State University.  
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 Upon evaluation of this project, the project leader found areas where this could improve 
the primary care provider’s management of chronic pain, but also areas for improvement to 
further enhance its use in practice. Monitoring is essential and having proper documentation of 
the evidence-based recommendations of chronic pain monitoring could only help providers, 
especially if litigation or safe practices ever came into question. However, it is also important to 
utilize the electronic health record to its full potential so these tools are improving efficiency and 
effectiveness, without increasing workload and documentation time of already stressed and 
overworked providers. Proper utilization of the EHR has many benefits including cost 
containment, error reduction, and improved compliance through clinical decision support and 
recommendations (Rothman, Leonard, & Vigoda, 2012).  
 Future research related to this practice improvement project should include continued 
evidence on ways to best monitor and care for the chronic pain population. Obtaining viewpoints 
of chronic pain patients could reveal important insight and may inspire new ways to improve 
compliance and cooperation. Another avenue to consider is reviewing the daily morphine 
equivalents of chronic pain patients to ensure providers are complying with the latest guidelines. 
Dangerous side effects, even death, are often related to an over-escalated dosing of opioid 
medications. Evidence suggests the risk for drug-related adverse events is higher in individuals 
prescribed opioids at doses equal to 50mg or more per day of morphine. Research has shown a 
direct correlation between maximum prescribed daily dose of opioids and risk for overdose death 
(Bohnert et al., 2011).  
Application to Other Doctor of Nursing Practice Roles  
 The design, development, implementation, and evaluation of this project utilized all roles 
considered essential for the Doctor of Nursing Practice (DNP). This role required leadership in 
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taking initiative to improve clinical practices with the end goal of positively influencing patient 
care. In combination with assisting providers in caring for chronic pain patients, this project 
inspired the project leader to be an advocate for chronic pain patients in ensuring their right to 
safe and effective pain management was being met. Continued education is another essential role 
for the DNP and throughout this process, the project leader was constantly learning and 
examining new research and evidence-based guidelines. Lastly, health promotion and prevention 
is an area where DNPs excel. Improving chronic pain management to improve overall health and 
prevent poor health outcomes was the overarching goal of this entire project. 
  
 
 
50 
REFERENCES 
Anson, P. (2016). CDC: Prescription opioid abuse costs $78.5 billion. Pain News Network. 
Retrieved from https://www.painnewsnetwork.org/stories/2016/9/15/cdc-prescription-
opioid-abuse-costs-785-billion-annually.  
Birnbaum, H., White, A., Schiller, M., Waldman, T., Cleveland, J., & Roland, C. (2011). 
Societal costs of prescription opioid abuse, dependence, and misuse in the United States. 
Pain Medicine, 12(4), 657-667.  
Bohnert A., Valenstein, M., Bair, M., Ganoczy, D., McCarthy, J., Ilgen, M., & Blow, F. (2013). 
Association between opioid prescribing patterns and opioid overdose-related 
deaths. Journal of American Medical Association, 305(13), 1315-1321.  
Brooks, M. (2015). Drug overdose now leading cause of injury-related deaths. Medscape. 
Retrieved from http://www.medscape.com/viewarticle/846636_print.  
Butler, S., Fernandez, K., Benoit, C., Budman, S., & Jamison, R. (2008). Validation of the 
revised screener and opioid assessment for patients with pain (SOAPP-R). The Journal of 
Pain, 9(4), 360-372. 
Centers for Disease Control and Prevention. (2016). CDC guideline for prescribing opioids for 
chronic pain- United States, 2016. Morbidity and Mortality Weekly Report, 65(1), 1-49.  
Cohen, D. J., Tallia, A. F., Crabtree, B. F., & Young, D. M. (2005). Implementing Health 
Behavior Change in Primary Care: Lessons From Prescription for Health. Annals of 
Family Medicine, 3(Suppl 2), s12–s19.  
Corbin, J. & Strauss, A. (1991). A nursing model for chronic illness management based upon the 
trajectory framework. Scholarly Inquiry for Nursing Practice, 5, 155-174.  
 
 
51 
Doody, C., Doody, O. (2011). Introducing evidence into nursing practice: Using the IOWA 
model. British Journal of Nursing, 20(11), 661-664. 
Fisherman, S. (2012). Responsible opioid prescribing: A guide for Michigan clinicians. 
Washington, D.C.: Waterford Life Sciences. 3 
Granger, B., Moser, D., Harrell, J., Sandelowski, M. & Ekman, I. (2007). A practical use of 
theory to study adherence. Progress in Cardiovascular Nursing, 22, 152-158. 
Harris, J. (2008). Management of expected and unexpected opioid-related side effects. The 
Clinical Journal of Pain, Supplement 10, S8-S13.  
Jamison, R., Butler, S., Budman, S., Edwards, R., & Wasan, A. (2010). Gender differences in 
risk factors for aberrant prescription opioid use. The Journal of Pain, 11(4), 312-320. 
Jamison, R. N., Scanlan, E., Matthews, M. L., Jurcik, D. C., & Ross, E. L. (2016). Attitudes of 
Primary Care Practitioners in Managing Chronic Pain Patients Prescribed Opioids for 
Pain: A Prospective Longitudinal Controlled Trial. Pain Medicine, 17(1), 99-113.  
Jones, R., Spradlin, A., Robinson, J., & Tragesser, S. (2014). Development and validation of the 
opioid prescription medication motives questionnaire: A four-factor model of reasons for 
use. Psychology of Addictive Behaviors, 28(4), 1290-1296. 
Katz et al. (2010). Usefulness of prescription monitoring programs for surveillance- analysis of 
Schedule II opioid prescription data in Massachusetts, 1996-2006. 
Pharmacodepidemiology and Drug Safety, 19, 115-123.  
Makam, A. N., Lanham, H. J., Batchelor, K., Samal, L., Moran, B., Howell-Stampley, T., & ... 
Halm, E. A. (2013). Use and satisfaction with key functions of a common commercial 
electronic health record: a survey of primary care providers. BMC Medical Informatics & 
Decision Making, 13(1), 1-7.  
 
 
52 
Manchikanti, L., Abdi, S., Atluri, S., Balog, C., Benyamin, R., Boswell, M., … Wargo, B. 
(2012). American Society of Interventional Pain Physicians (ASIPP) guidelines for 
responsible opioid prescribing in chronic non-cancer pain: Part 2- Guidance. Pain 
Physician, 15, S67-S116. 
Manchikanti, L., Atluri, S., Trescot, A., & Giordano, J. (2008). Monitoring opioid adherence in 
chronic pain patients: Tools, techniques and utility. Pain Physician, Special Issue 11, 1-
26. 
Minnesota Department of Human Services. (2016). Opioid Prescribing Improvement Program. 
Retrieved from http://www.mn.gov/dhs-stat/images/opioid-prescribing-improvement-
program.pdf.  
Minnesota Prescription Monitoring Program. (2015). General Program FAQ’s. Retrieved from 
www.pmp.pharmacy.state.mn.us.  
Moore, T., Jones, T., Browder, J., Daffron, S., & Passik, S. (2009). A comparison of common 
screening methods for predicting aberrant drug-related behavior among patients receiving 
opioids for chronic pain management. Pain Medicine, 10(8), 1426-1433. 
PDMP Center for Excellence. (2014). Mandating PDMP participation by medical providers: 
Current status and experience in selected states. Retrieved from 
http://www.pdmpexcellence.org/sites/all/pdfs/COE_briefing_mandates_2nd_rev.pdf.  
Rich, B. & Webster, L. (2011). A review of forensic implications of opioid prescribing with 
examples from malpractice cases involving opioid-related overdose. Pain Medicine, 12, 
S59-S65. 
Rothman, B., Leonard, J. C., & Vigoda, M. M. (2012). Future of Electronic Health Records: 
Implications for Decision Support. Mount Sinai Journal of Medicine, 79(6), 757-768.  
 
 
53 
Schneider, J. (2014). Opioid prescribing part 2: Appropriate documentation of follow-up visits. 
Practical Pain Management, 36-39. Retrieved from 
http://www.jenniferschneider.com/pdf/OpioidPrescribingPart2Schneider.pdf.  
The Office for Human Research Protections. (2016). Human subjects regulations decision charts. 
U.S. Department of Health & Human Services. Retrieved from 
http://www.hhs.gov/ohrp/policy/checklists/decisioncharts.html#c2.  
U.S. Department of Justice: Drug Enforcement Administration. (2011). State Prescription Drug 
Monitoring Programs. Retrieved from 
http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm.  
Warner, M., Chen, L., Makuc, D., Anderson, R., & Minino, A. (2011). Drug poisoning deaths in 
the United States, 1980-2008. NCHS Data Brief, 81. Retrieved from 
www.cdc.gov/nchs/data/databriefs/db81.pdf.  
Wasan, A., Ross, E., Michna, E., Chibnik, L., Greenfield, S., Weiss, R., & Jamison, R. (2012). 
Craving of prescription opioids in patients with chronic pain: A longitudinal outcomes 
trial. The Journal of Pain, 13(2), 146-154. 
  
 
 
54 
APPENDIX A. PERMISSION TO USE IOWA MODEL 
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APPENDIX B. PRE-IMPLEMENTATION PROVIDER SURVEY 
1. What is your current level of satisfaction with the monitoring of chronic pain patients? 
o 1- Not at all satisfied 
o 2- Slightly satisfied 
o 3- Moderately satisfied 
o 4- Very satisfied 
o 5- Extremely satisfied 
2. To your best knowledge, what percentage of your chronic pain patients have the 
following in place:  
o Signed Lake Region Healthcare Pain Contract within last year 
o 0-20 % 
o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
o Urine drug screen within last 6 months 
o 0-20 % 
o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
o Pharmacy Drug Monitoring Program checked with last prescription refill/renewal 
o 0-20 % 
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o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
o Pain Visit within the last 3-4 months 
o 0-20 % 
o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
3. To what extent do you feel the electronic health record is easy to use in regards to 
searching for monitoring elements (last UDS, last PDMP checked, signed contract)? 
o Not at all  
o Slightly user-friendly 
o Somewhat user-friendly 
o Moderately user-friendly 
o Extremely user-friendly 
4. How do you currently document pain visits? 
o Free text 
o Dictate  
o Use a template 
o Every patient is different 
o Other:  
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5. What is your current level of satisfaction in regards to your system’s ability to allow you 
to easily document pain visits that cover all the necessary elements of pain assessments 
(analgesia, activities of daily living, adverse effects, aberrant behaviors, and affect)? 
o 1- Not at all satisfied 
o 2- Slightly satisfied 
o 3- Moderately satisfied 
o 4- Very satisfied 
o 5- Extremely satisfied 
6. What is going well currently with your chronic pain management in your practice? 
 
 
 
7. What barriers or concerns do you have with chronic pain management in your practice? 
 
 
 
8. What other comments do you have?  
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APPENDIX C. POST-IMPLEMENTATION SURVEY 
1. What is your current level of satisfaction with the monitoring of chronic pain patients? 
o 1- Not at all satisfied 
o 2- Slightly satisfied 
o 3- Moderately satisfied 
o 4- Very satisfied 
o 5- Extremely satisfied 
2. To your best knowledge, what percentage of your chronic pain patients have the 
following in place:  
o Signed Lake Region Healthcare Pain Contract within last year 
o 0-20 % 
o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
o Urine drug screen within last 6 months 
o 0-20 % 
o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
o Pharmacy Drug Monitoring Program checked with last prescription refill/renewal 
o 0-20 % 
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o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
o Pain Visit within the last 3-4 months 
o 0-20 % 
o 21-40% 
o 41-60% 
o 61-80% 
o 81-100% 
3. To what extent do you feel the electronic health record is easy to use in regards to 
searching for monitoring elements (last UDS, last PDMP checked, signed contract)? 
o Not at all  
o Slightly user-friendly 
o Somewhat user-friendly 
o Moderately user-friendly 
o Extremely user-friendly 
4. How do you currently document pain visits? 
o Free text 
o Dictate  
o Use a template 
o Every patient is different 
o Other:  
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5. What is your current level of satisfaction in regards to your system’s ability to allow you 
to easily document pain visits that cover all the necessary elements of pain assessments 
(analgesia, activities of daily living, adverse effects, aberrant behaviors, and affect)? 
o 1- Not at all satisfied 
o 2- Slightly satisfied 
o 3- Moderately satisfied 
o 4- Very satisfied 
o 5- Extremely satisfied 
6. What is going well currently with your chronic pain management in your practice? 
 
 
 
7. What barriers or concerns do you have with chronic pain management in your practice? 
 
 
8. When caring for a chronic pain patient, how often did you use the Chronic Pain Flow 
Sheet? 
o Never 
o Almost Never 
o Occasionally/Sometimes 
o Almost Every Time 
o Every Time 
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9.  When seeing a patient for chronic pain, how often do you use the Pain Visit Template? 
o Never 
o Almost Never 
o Occasionally/Sometimes 
o Almost Every Time 
o Every Time 
10.  What is the likelihood that you will continue to use the Chronic Pain Flow Sheet and 
Pain Visit Template? 
o 1 – Extremely unlikely 
o 2 – Unlikely 
o 3 – Neutral 
o 4 – Likely 
o 5 – Extremely likely 
11. What other comments do you have?  
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APPENDIX D. IRB APPROVAL  
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APPENDIX E. BRIEF PAIN INVENTORY 
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APPENDIX F. EXECUTIVE SUMMARY 
Background and Significance 
 Opioid abuse is a growing epidemic. Deaths from overdoses are increasing in number. 
Healthcare costs continue to rise due to opioid abuse and inadequate chronic pain management. 
Primary care providers feel inexperienced and uncomfortable with managing opioid therapy 
safely and effectively. To address this problem, a monitoring and documentation tool was 
developed within the electronic health record to assist primary care providers serving chronic 
pain patients in a rural primary care clinic. The purpose of this project was to implement 
evidence-based practices for prescribing opioids for chronic pain management and monitoring. 
Project Summary 
 The chronic pain flow sheet was implemented in the charts of chronic pain patients at a 
rural primary care clinic and data was inputted based on four important monitoring parameters. 
Parameters were determined based on extensive literature review using evidence-based research. 
Data was collected regarding a pain visit signed and filed within the last 12 months, prescription 
drug monitoring program checked within the last six months, urine drug screen performed within 
the last six months, and a documented pain visit within the last four months.  
 The project leader held a meeting with the three providers at the clinic and delivered a 
survey regarding their current practice of caring for chronic pain patients. The providers were 
also educated on the presence of the chronic pain flow sheet and the availability of the pain visit 
template. Survey questions were answered along with open discussion to allow the project leader 
to collect qualitative data on the providers’ view on caring and managing chronic pain patients. 
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Results 
Initial Chart Review 
Results of the initial chart review showed 19.67% of patients had a signed contract in the 
electronic medical record that was filed within the last 12 months. The prescription drug 
monitoring program was checked with the last six months in 22.95% of patients. A urine drug 
screen was performed within the last six months in 26.23% of the patients. A pain visit was 
documented within the last four months in 72.13% of patients.  
Ideally, chronic pain patients meet all the parameters to ensure safe and effective chronic 
pain management. In the initial review, all four parameters were met in 8.2% of the patients. 
Three parameters were met in 11.48% of patients, two parameters met in 16.39% of patients, one 
parameter met in 44.26% of patients, and no parameters were met in 19.67% of patients.  
Pre-Implementation Survey 
The pre-implementation survey was dispersed to the three providers at the clinic. 
Questions were asked regarding level of satisfaction of the monitoring of chronic pain patients, 
the percentage of their patients that met the pain monitoring parameters, the usability of the 
electronic medical record for documenting pain visits, and the perception of the electronic 
medical record’s ability to monitor chronic pain patients. The last three questions allowed for 
more open-ended answers regarding what is going well with chronic pain patients, barriers to 
managing chronic pain, and any additional comments they may have.  
Survey results overall showed a moderately-slightly satisfied view on chronic pain 
management and providers had a higher estimate of those monitoring parameters being met in 
their chronic pain patients. Responses varied in regards to the usability of the EMR from not 
easy to use to moderately easy to use.  
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The fourth question asked how the providers document pain visits and options included: 
free text, dictate, use a template, every patient is different, and other. Two providers chose 
dictate and one provider chose free text. 
The fifth question of the survey asked providers about their current level of satisfaction in 
regards to the system’s ability to allow for pain visits to be easily documented and ensure they 
cover all the necessary elements of pain assessments (analgesia, activities of daily living, adverse 
effects, aberrant behaviors, and affect). One provider felt not at all satisfied with the system and 
two providers felt only slightly satisfied with the current system. 
The final three questions of the survey were open-ended and allowed for individual 
answers and opinions. Question six simply asked, “What is going well currently with your 
chronic pain management in your practice?”. Answers included, “using forms from paper 
charts”, “dictating notes”, and “printing Rx’s”. One provider said, “we are decreasing the amount 
of people and dosages on many of the patients” and also mentioned “using PT, massage, topicals, 
etc. instead”.  
The seventh question of the survey inquired about the barriers and concerns providers 
have with chronic pain management in their practice. Providers responded with “vague structures 
from regulating agencies”, “EHR issues”, and “lack of consultants to review patients needs and 
care plan”. Other barriers or concerns mentioned were “no good tracking system here with 
prescriptions- Sanford has prescription monitoring where they are automatically generated 
monthly and tracked by a nurse”, “finding data in EHR pertaining to pain visit”, and “charts 
being flagged as pain contract present”.  
The final question on the survey that led to open discussion was “what other comments 
do you have?”. Providers mentioned frustrations with having no second opinion available 
 
 
69 
regarding their chronic pain patients, guidelines being difficult to follow and treat patients 
accordingly, and feeling that the practice of treating chronic pain is difficult. Providers also 
mentioned the change in practice over the past twenty years. For example, twenty years ago 
providers were encouraged to push medications and if a provider did not treat pain, they were 
considered a bad provider. Now, regulatory agencies are enforcing providers to reduce or stop 
opioids at all costs. One provider stated “a flow sheet would be very helpful”.  
Six-Month Chart Review  
A six-month chart review was performed to see if the chronic pain flow sheet was being 
utilized and the parameters were updated and being met. In regards to presence of a pain contract 
within the last 12 months, 25% of patients met this parameter. In comparison to the initial chart 
review, there was a 5.33% increase in pain contracts. Eleven and a half percent of patients had 
their PDMP checked within the last six months. However, a 5% decrease was seen in checking 
PDMPs compared to the initial chart review. Pain visits were present in 69.2% of patients, which 
was down 2.9% since the initial chart review.  
In regards to meeting the chronic pain monitoring parameters, all four parameters were 
met in 7.7% of patients. Three parameters were met in 5.8% of patients, two parameters met in 
19.2% of patients, and one parameter met in 46.2% of patients. No parameters were met in 
21.2% of patients.  
Post-Implementation Survey 
Post-implementation surveys were dispensed to the clinic providers in January 2017 and 
included the first seven questions from the initial survey plus additional questions. The eighth 
question on the survey asked about the frequency of use of the chronic pain flow sheet on a scale 
of never to every time. One provider selected every time, one selected never, and another 
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selected almost never. The ninth question asked about the frequency of the use of the pain visit 
template. Responses included never, almost never, and almost every time (if started by nursing at 
the beginning of the visit). The tenth question asked about the likelihood of continuing use of the 
flow sheet and template on a scale of extremely unlikely (1) to extremely likely (5). Two 
providers were neutral in responding to this question and the third provider responded as being 
extremely likely to continue the use of the designed tools.  
The survey asked for suggestions on how to make the flow sheet and pain visit template 
more efficient and user-friendly. Providers felt chronic pain management is a difficult and time- 
consuming task. One suggestion was to make the flow sheet be auto-populated somehow so it 
requires less documentation and data entry by the user. The final question of the survey asked for 
any comments providers have. Comments included “need to do better job on my part of re-
emphasizing to nurses to use template”, and “it is difficult to separate pain treatment from non-
pain care”.  
Recommendations 
 Despite data analysis not showing improvement in chronic pain monitoring parameters, 
the project leader recommends this project be continued at the clinic and expand to the other 
healthcare system’s clinic sites. The project leader does think the pain visit template and chronic 
pain flow sheet have the potential to help primary care providers manage their chronic pain 
patients. Because these tools were developed within AllScripts, these tools are available to not 
only the rural clinic but the entire healthcare network. This project has the potential to positively 
impact the practice of several providers and may result in a network-wide improvement in the 
management of chronic pain patients. Considering opioid abuse and chronic pain is at the 
 
 
71 
forefront of medicine and considered a national priority to reduce its negative effects, primary 
care providers may find it imperative and beneficial to utilize the tools created. 
